Antibacterial Anacardic Acid Derivatives

ACS Infect Dis. 2020 Jul 10;6(7):1674-1685. doi: 10.1021/acsinfecdis.9b00378. Epub 2020 Jun 28.

Abstract

We report on the antibacterial activity of five phenolic lipids derived from anacardic acid characterized by increasing alkyl chain lengths with 6, 8, 10, 12, or 14 carbon atoms. The compounds were profiled for their physicochemical properties, transport across epithelial monolayers, cytotoxicity, and antibacterial activity as compared to common antibiotics. No cytotoxicity was reported in cell lines of fibroblast, hepatic, colorectal, or renal origin. C10 and C12 significantly increased the survival in a Galleria mellonella model infected with multi-drug-resistant Staphylococcus aureus (MRSA) or vancomycin-resistant Enterococci (VRE) as compared to the untreated control group. Future studies are required to corroborate these findings in relevant animal model systems of infection.

Keywords: Galleria mellonella; VRE; anacardic acid; biofilm inhibition; methicillin-resistant Staphylococcus aureus.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anacardic Acids / pharmacology
  • Animals
  • Anti-Bacterial Agents / pharmacology
  • Methicillin-Resistant Staphylococcus aureus*
  • Vancomycin-Resistant Enterococci*

Substances

  • Anacardic Acids
  • Anti-Bacterial Agents
  • anacardic acid